Afflatus Pharmaceuticals Private Limited, a active private limited company, was established on 08 September 2005 in New Dldehi, Delhi, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U00304DL2005PTC140510. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.
Formerly known as Allenbury Biotech Private Limited. It upholds a compliant status. Employing 12 professional, Its leadership includes Kamal Chhabra (Director), Tilak Raj (Director). Past directors included Vikas Pruthi, Deepanshu Pruthi, Nishchal Pruthi. It holds ₹9.28 Cr open charges and ₹3.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at E-29 Amar Colonylajpat Nagar Iv New Dldehi, New Dldehi, Delhi, 110024.
U00304DL2005PTC140510
140510
08 September 2005
₹2.00 Cr
₹2.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Afflatus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamal Chhabra | Director | 23 Apr 2018 | Current |
| Tilak Raj | Director | 23 Apr 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Mar 2018 | Past |
| Pramod Abcsdd | Director | 13 Jun 2019 | Past |
| Pramod Abcsdd | Director | 13 Jun 2019 | Past |
| Pramod Abcsdd | Director | 25 Jun 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Afflatus Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 136.05% increase. The company also saw a substantial improvement in profitability, with a 155.54% increase in profit. The company's net worth Soared by an impressive increase of 23.25%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Afflatus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹92,839,000.00
₹30,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2025 | Others | ₹1.50 Cr | Open |
| 30 Apr 2025 | Others | ₹2.84 M | Open |
| 20 Dec 2024 | Others | ₹3.00 Cr | Open |
| 08 Nov 2023 | Others | ₹1.50 Cr | Open |
| 01 Sep 2021 | Others | ₹1.50 Cr | Open |
Explore comprehensive loan charge details -
Afflatus Pharmaceuticals has a workforce of 12 employees as of Feb 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Afflatus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Afflatus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 101089978 was registered on 30 Apr 2025. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 0.28 Cr with Charge ID 101089972 was registered on 30 Apr 2025. was documented.
Progress on A charge with Others amounted to Rs. 3.00 Cr with Charge ID 101022683 was registered on 20 Dec 2024. was documented.
The activity Afflatus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Afflatus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity A charge with Others amounted to Rs. 1.50 Cr with Charge ID 100828548 was registered on 08 Nov 2023. was completed.
The CIN of Afflatus Pharmaceuticals Private Limited is U00304DL2005PTC140510.
Afflatus Pharmaceuticals Private Limited is headquartered at E-29 Amar Colonylajpat Nagar Iv New Dldehi, New Dldehi, Delhi, 110024.
Afflatus Pharmaceuticals Private Limited was incorporated on 08 September 2005.
The current directors of Afflatus Pharmaceuticals Private Limited are
The primary industry of Afflatus Pharmaceuticals Private Limited is Manufacturing.
Afflatus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Afflatus Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Afflatus Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX